Home
RETO
RETO News

Latest ReTo Eco-Solutions Inc. (RETO) News on July 27, 2024

ReTo Eco-Solutions, Inc. to Hold Its Annual Meeting of Shareholders at Its Headquarters on August 5, 2024 Beijing Time

PR Newswire

a month ago

ReTo Eco-Solutions, Inc. to Hold Its Annual Meeting of Shareholders at Its Headquarters on August 5, 2024 Beijing Time

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

2 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

2 months ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

2 months ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

2 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

2 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

2 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

2 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

2 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

2 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

2 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

2 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

ReTo Announces Filing of Annual Report on Form 20-F

PR Newswire

2 months ago

ReTo Announces Filing of Annual Report on Form 20-F

ReTo Regained Compliance with Nasdaq's Minimum Bid Price Requirement and Received Extension on Compliance with Nasdaq's Minimum Stockholders' Equity Rule

PR Newswire

4 months ago

ReTo Regained Compliance with Nasdaq's Minimum Bid Price Requirement and Received Extension on Compliance with Nasdaq's Minimum Stockholders' Equity Rule

ReTo Eco-Solutions, Inc. Announces Share Combination

PR Newswire

5 months ago

ReTo Eco-Solutions, Inc. Announces Share Combination

ReTo Presents at Big 5 Construct Saudi 2024

PR Newswire

5 months ago

ReTo Presents at Big 5 Construct Saudi 2024

GameSquare Officially Launches Moonlight Studios To Further Expand Its World-Building Division Led by Former Pro Fortnite Player

ACCESSWIRE

6 months ago

GameSquare Officially Launches Moonlight Studios To Further Expand Its World-Building Division Led by Former Pro Fortnite Player

Meta Materials Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

ACCESSWIRE

6 months ago

Meta Materials Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s

Business Wire

6 months ago

IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s

Coda Octopus Group Sets Fiscal Year 2023 Earnings Conference Call for Monday, January 29, 2024 at 10 a.m. Eastern Time

GlobeNewswire

6 months ago

Coda Octopus Group Sets Fiscal Year 2023 Earnings Conference Call for Monday, January 29, 2024 at 10 a.m. Eastern Time

IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial

Business Wire

6 months ago

IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial

GlocalMe Unveils Next-Level Global Connectivity Solutions at CES 2024

PR Newswire

7 months ago

GlocalMe Unveils Next-Level Global Connectivity Solutions at CES 2024

Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results

GlobeNewswire

7 months ago

Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results

ReTo Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

PR Newswire

7 months ago

ReTo Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Ramaco Chairman and CEO Scheduled to Appear on Sky News on Friday, January 5, and BBC World TV on Wednesday, January 10

PR Newswire

7 months ago

Ramaco Chairman and CEO Scheduled to Appear on Sky News on Friday, January 5, and BBC World TV on Wednesday, January 10

ReTo Eco-Solutions, Inc. Announces First Half 2023 Financial Results

PR Newswire

7 months ago

ReTo Eco-Solutions, Inc. Announces First Half 2023 Financial Results

Spectaire Announces Integration Between AireCore™ and Geotab, Delivering Enhanced Emissions Monitoring

GlobeNewswire

7 months ago

Spectaire Announces Integration Between AireCore™ and Geotab, Delivering Enhanced Emissions Monitoring

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

GlobeNewswire

7 months ago

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

InvestorPlace

7 months ago

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

Red Cat Holdings Selected by U.S. Army as Finalist for Short Range Reconnaissance Tranche 2 Drone Program

GlobeNewswire

7 months ago

Red Cat Holdings Selected by U.S. Army as Finalist for Short Range Reconnaissance Tranche 2 Drone Program

Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models

GlobeNewswire

8 months ago

Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models

1895 BANCORP OF WISCONSIN, INC. ANNOUNCES BALANCE SHEET REPOSITIONING

PR Newswire

8 months ago

1895 BANCORP OF WISCONSIN, INC. ANNOUNCES BALANCE SHEET REPOSITIONING

eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients

GlobeNewswire

8 months ago

eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

GlobeNewswire

8 months ago

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

Lightbridge CEO Seth Grae to be Interviewed on BNN Bloomberg Tomorrow at 8:30am ET

GlobeNewswire

8 months ago

Lightbridge CEO Seth Grae to be Interviewed on BNN Bloomberg Tomorrow at 8:30am ET

EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody

Benzinga

8 months ago

EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody

ReTo Eco-Solutions Resumed Its Participation in the BIG 5 Global Exhibition

PR Newswire

8 months ago

ReTo Eco-Solutions Resumed Its Participation in the BIG 5 Global Exhibition

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

PR Newswire

8 months ago

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

Hubzu Expands Collaboration with NCST (National Community Stabilization Trust) to Increase Access to Affordable Housing

GlobeNewswire

8 months ago

Hubzu Expands Collaboration with NCST (National Community Stabilization Trust) to Increase Access to Affordable Housing

eFFECTOR Receives U.S. FDA Fast Track Designation for Zotatifin in Combination with Fulvestrant and Abemaciclib for Treatment of ER+/HER2- Advanced Metastatic Breast Cancer

GlobeNewswire

8 months ago

eFFECTOR Receives U.S. FDA Fast Track Designation for Zotatifin in Combination with Fulvestrant and Abemaciclib for Treatment of ER+/HER2- Advanced Metastatic Breast Cancer

Cooper Standard's Venkat Receives ORBIE® Award by MichiganCIO

PR Newswire

8 months ago

Cooper Standard's Venkat Receives ORBIE® Award by MichiganCIO

New Strong Sell Stocks for November 24th

Zacks

8 months ago

New Strong Sell Stocks for November 24th

Investors in Luxfer Holdings (NYSE:LXFR) have unfortunately lost 59% over the last five years

Simply Wall St.

8 months ago

Investors in Luxfer Holdings (NYSE:LXFR) have unfortunately lost 59% over the last five years

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

8 months ago

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Maquia Capital Acquisition Corporation Announces Filing of Registration Statement on Form S-4 in Connection With Its Proposed Business Combination with Immersed Inc.

GlobeNewswire

8 months ago

Maquia Capital Acquisition Corporation Announces Filing of Registration Statement on Form S-4 in Connection With Its Proposed Business Combination with Immersed Inc.

Associated Press Finance

8 months ago

Pluri: Fiscal Q1 Earnings Snapshot

Vicarious Surgical Reports Third Quarter 2023 Financial Results

Business Wire

8 months ago

Vicarious Surgical Reports Third Quarter 2023 Financial Results

Business Wire

9 months ago

CuriosityStream Announces Third Quarter 2023 Financial Results

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Core Molding Technologies Inc Earnings Call

Associated Press Finance

9 months ago

Vista Gold: Q3 Earnings Snapshot

Vista Gold Corp. Announces Third Quarter Financial Results and Corporate Update

Business Wire

9 months ago

Vista Gold Corp. Announces Third Quarter Financial Results and Corporate Update

Business Wire

9 months ago

CuriosityStream To Report Third Quarter 2023 Financial Results on November 9, 2023

Associated Press Finance

9 months ago

Core Molding Technologies: Q3 Earnings Snapshot

Core Molding Technologies Reports Fiscal 2023 Third Quarter Results

GlobeNewswire

9 months ago

Core Molding Technologies Reports Fiscal 2023 Third Quarter Results

Newsfile

9 months ago

Snow Lake Resources Ltd. Announces Participation in Red Cloud's 2023 Fall Mining Showcase in Toronto

Where Food Comes From, Inc. Schedules Third Quarter Earnings Call

GlobeNewswire

9 months ago

Where Food Comes From, Inc. Schedules Third Quarter Earnings Call

Allot (NASDAQ:ALLT shareholders incur further losses as stock declines 14% this week, taking three-year losses to 84%

Simply Wall St.

9 months ago

Allot (NASDAQ:ALLT shareholders incur further losses as stock declines 14% this week, taking three-year losses to 84%

Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023)

Business Wire

9 months ago

Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023)

YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

PR Newswire

9 months ago

YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

Share on Social Networks: